Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women
- PMID: 21763939
- PMCID: PMC3652579
- DOI: 10.1016/S0140-6736(11)60878-7
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women
Conflict of interest statement
We declare that we have no conflicts of interest.
Figures
Comment in
-
Antiretrovirals for HIV prevention: translating promise into praxis.Lancet. 2011 Jul 16;378(9787):206-8. doi: 10.1016/S0140-6736(11)61056-8. Lancet. 2011. PMID: 21763922 No abstract available.
References
-
- FHI. [accessed April 18, 2011];FHI statement on the FEM-PrEP HIV prevention study. 2011 http://minilicious.wordpress.com/2011/04/18/fhi-statement-on-the-fem-pre...
-
- UNAIDS. UNAIDS Report on the global AIDS Epidemic 2010. Geneva: Joint United Nations Programme on HIV/AIDS; 2010. [accessed Feb 11, 2011]. http://www.unaids.org/globalreport/
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
